- Home
- ULY vs SXTP Comparison
ULY vs SXTP Comparison
Compare ULY & SXTP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ULY | SXTP |
|---|---|---|
| Founded | 2013 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8M | 4.5M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | ULY | SXTP |
|---|---|---|
| Price | $2.15 | $3.49 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $11.50 | ★ $17.60 |
| AVG Volume (30 Days) | 400.4K | ★ 10.5M |
| Earning Date | 03-11-2026 | 03-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $127,932,000.00 | $1,364,945.00 |
| Revenue This Year | N/A | $146.28 |
| Revenue Next Year | $18.95 | $24.61 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 202.10 |
| 52 Week Low | $1.74 | $1.36 |
| 52 Week High | $17.99 | $17.68 |
Technical Indicators
Market Signals| Indicator | ULY | SXTP |
|---|---|---|
| Relative Strength Index (RSI) | 46.49 | 52.63 |
| Support Level | $2.01 | $3.56 |
| Resistance Level | $2.23 | $4.19 |
| Average True Range (ATR) | 0.37 | 0.51 |
| MACD | -0.01 | -0.19 |
| Stochastic Oscillator | 19.64 | 3.85 |
Price Performance
Historical ComparisonAbout ULY Urgent.ly Inc.
Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and to long wait times. Urgently offers an alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.